Condition

Disease Progression

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 10 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials10

Recruiting0

Common interventions18

Lead sponsors shown9

Clinical trials

10 shown

Enhancing Gait Using Alternating-Frequency DBS in Parkinson DiseaseNCT05022147 · 2021-10-04

ACTIVE_NOT_RECRUITING

Treatment Resistance Following Anti-cancer TherapiesNCT04436120 · 2019-02-13

TERMINATED

A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDRNCT02681809 · 2015-12-01

TERMINATED

Dysarthria in Parkinson's Disease: Lusophony vs. Francophony ComparisonNCT02753192 · 2014-01-01

UNKNOWN

Madrid Project on the Management of Chronic Obstructive Pulmonary Disease With Home TelemonitoringNCT02499068 · 2013-12-01

COMPLETED

Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisNCT01684761 · 2012-08-01

COMPLETED

Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in KenyaNCT01425073 · 2012-02-01

COMPLETED

Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD?NCT01507415 · 2011-11-01

COMPLETED

Efficacy Study of Water Drinking on PKD Progression.NCT01348035 · 2011-04-01

COMPLETED

Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary DiseaseNCT01515709 · 2011-04-01

COMPLETED

Common interventions

Alternating, 10 sec High-Frequency, 10 sec Low-Frequency StimulationDEVICE1 Alternating, 10 sec High-Frequency, 50 sec Low-Frequency StimulationDEVICE1 Alternating, 50 sec High-Frequency, 10 sec Low-Frequency StimulationDEVICE1 Alternating, 50 sec High-Frequency, 50 sec Low-Frequency StimulationDEVICE1 De novo tumor tissue biopsyPROCEDURE1 Discontinue TMP/SMZ prophylaxisOTHER1 High-Frequency-Only StimulationDEVICE1 Low-Frequency-Only StimulationDEVICE1 ocriplasmin 0.0625mgDRUG1 ocriplasmin 0.125mgDRUG1 OFF Dopaminergic MedicationDRUG1 ON Dopaminergic MedicationDRUG1 PatientsOTHER1 PlaceboBIOLOGICAL1 Research blood drawsPROCEDURE1 Sham injectionDRUG1 TcelnaBIOLOGICAL1 TelehealthDEVICE1

Leading sponsors

Royal Brompton & Harefield NHS Foundation Trust 2 Arturo Garcia 1 Centre National de la Recherche Scientifique, France 1 James Liao 1 Kyorin University 1 Opexa Therapeutics, Inc. 1 Pfizer 1 ThromboGenics 1 University of Washington 1

Trial status mix

COMPLETED6

TERMINATED2

ACTIVE_NOT_RECRUITING1

UNKNOWN1

Phase mix

NA4

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.